The total return for Abbott Laboratories (ABT) stock is -30.21% over the past 12 months vs. +24.34% for the S&P 500. So far it's up -26.34% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (31.61%) | (3.55%) | (3.50%) | +8.91% | +9.12% | +7.73% |
| Total Return CAGR | (30.21%) | (1.58%) | (1.67%) | +10.97% | +11.39% | +10.22% |
| Revenue CAGR | +6.59% | +2.83% | +3.87% | +8.27% | +1.42% | +3.63% |
| Net Income CAGR | (53.54%) | +2.64% | +1.86% | +9.88% | +2.26% | +3.11% |
| EPS CAGR | (51.26%) | (1.72%) | +8.22% | +2.23% | +1.50% | +2.76% |
| Free Cash Flow CAGR | +10.84% | +2.64% | (0.61%) | +15.46% | (0.59%) | +2.33% |
| Operating Cash Flow CAGR | +5.75% | +3.01% | (0.74%) | +12.67% | +0.17% | +2.46% |
| Dividends CAGR | +7.28% | +7.87% | +10.39% | +9.41% | +7.26% | +7.85% |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Abbott Laboratories (ABT)
| Year | Start Value | End Value | ABT Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | 2449.34 | 1804.10 | (26.34%) | +8.38% | (34.72%) |
| 2025 | 2169.65 | 2449.34 | +12.89% | +17.72% | (4.83%) |
| 2024 | 2069.70 | 2169.65 | +4.83% | +24.89% | (20.06%) |
| 2023 | 2023.88 | 2069.70 | +2.26% | +26.19% | (23.93%) |
| 2022 | 2551.81 | 2023.88 | (20.69%) | (18.17%) | (2.52%) |
| 2021 | 1954.81 | 2551.81 | +30.54% | +28.74% | +1.80% |
| 2020 | 1527.16 | 1954.81 | +28.00% | +18.37% | +9.63% |
| 2019 | 1250.78 | 1527.16 | +22.10% | +31.22% | (9.12%) |
| 2018 | 969.31 | 1250.78 | +29.04% | (4.56%) | +33.60% |
| 2017 | 637.69 | 969.31 | +52.00% | +21.70% | +30.30% |
